FDA to Review Huntington's Gene Therapy

03 Nov 2026 0 comments

Dutch gene therapy developer uniQure said on Monday the US FDA had accepted its application ⁠for its Huntington's disease treatment and would decide on the drug by May 1,...
Reuters Health Information

Source: Medscape Neurology Published 02 Nov 2026 Imported 03 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment